Fundamental dimension Equity attribute | ENCCPeer $0.018▲+1.69% Cap $2.70MP/E -180.0x QuantScore27/100 | ABLTLeader $1.000.00% Cap $32.33KP/E -0.0x QuantScore32/100 | ADHCPeer $0.0005▲+6.38% Cap $1.20MP/E -2.5x QuantScore18/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
43/100 |
52/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 10/100 | 20/100 |
Growth Revenue / earnings growth & margins | 0/100 | 9/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -180.0x | -0.0x | -2.5x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -84.2x | -35.0x | -1.3x |
Price / Sales | — | 0.0x | — |
Price / Free Cash Flow | — | -0.0x | — |
PEG ratio | -1.80 | 0.00 | -0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | -33.58 (Distress) | 1.57 (Distress) | -601.28 (Distress) |
Total debt / equity | 0.00 | 1.80 | -0.07 |
Quick ratio | — | 0.5x | 0.0x |
Interest coverage | — | -3.7x | -635.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | +1.7% | — |
Net income growth YoY | -70.0% | -0.1% | -38.5% |
Gross margin (TTM) | 0.0% | 23.1% | 0.0% |
Operating margin (FY) | — | 0.5% | — |
FCF margin (FY) | — | -3.1% | — |
5. Trailing price performancePrice change over period |
1M return | +7.1% | 0.0% | +25.0% |
3M return | +12.5% | 0.0% | +25.0% |
6M return | +100.0% | -98.8% | -16.7% |
Year to date | -21.7% | -98.6% | -16.7% |
1Y return | -60.9% | -98.7% | -77.8% |
3Y return | +17900.0% | -99.3% | -62.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.1251 -795.2% premium | $6,498.16 +649716.5% upside | $-0.0019 -482.8% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |